Fox Run Management L.L.C. increased its position in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 121.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,166 shares of the technology company's stock after purchasing an additional 22,057 shares during the quarter. Fox Run Management L.L.C.'s holdings in Koninklijke Philips were worth $1,020,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of PHG. Colonial Trust Co SC lifted its holdings in shares of Koninklijke Philips by 724.0% in the fourth quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company's stock worth $36,000 after acquiring an additional 1,238 shares during the last quarter. Bessemer Group Inc. lifted its holdings in shares of Koninklijke Philips by 2,935.4% in the first quarter. Bessemer Group Inc. now owns 1,973 shares of the technology company's stock worth $51,000 after acquiring an additional 1,908 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Koninklijke Philips by 1,170.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,439 shares of the technology company's stock worth $62,000 after acquiring an additional 2,247 shares during the last quarter. Castlekeep Investment Advisors LLC bought a new position in shares of Koninklijke Philips in the fourth quarter worth about $114,000. Finally, Allworth Financial LP lifted its holdings in shares of Koninklijke Philips by 16.2% in the first quarter. Allworth Financial LP now owns 4,638 shares of the technology company's stock worth $115,000 after acquiring an additional 645 shares during the last quarter. Institutional investors own 13.67% of the company's stock.
Analyst Ratings Changes
Separately, Wall Street Zen cut shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy".
Get Our Latest Report on PHG
Koninklijke Philips Stock Down 0.2%
PHG stock opened at $27.24 on Friday. The stock has a market capitalization of $26.23 billion, a P/E ratio of 143.34, a price-to-earnings-growth ratio of 0.74 and a beta of 0.75. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.69. Koninklijke Philips N.V. has a 12 month low of $21.48 and a 12 month high of $32.91. The firm has a 50-day moving average price of $24.71 and a 200-day moving average price of $25.01.
Koninklijke Philips (NYSE:PHG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.12. The business had revenue of $5.05 billion during the quarter, compared to analyst estimates of $4.35 billion. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. As a group, equities research analysts anticipate that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.
Koninklijke Philips Company Profile
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.